Swim with the WHALES!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AXXA Chart - Another green day...Bullish! Buy signal triggered on Stochastic as well. News will just send this parabolic for us.
Very nice official twitter update:
$AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
— Exxegroup (@exxegroup) April 22, 2022
$AXXA Chart - Another green day...Bullish! Buy signal triggered on Stochastic as well. News will just send this parabolic for us.
Very nice official twitter update:
$AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
— Exxegroup (@exxegroup) April 22, 2022
$AXXA Chart - Another green day...Bullish! Buy signal triggered on Stochastic as well. News will just send this parabolic for us.
Very nice official twitter update:
$AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
— Exxegroup (@exxegroup) April 22, 2022
$AXXA Twitter update: $AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
$AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
— Exxegroup (@exxegroup) April 22, 2022
$AXXA Twitter update - $AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
$AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
— Exxegroup (@exxegroup) April 22, 2022
$AXXA Twitter update - $AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
$AXXA Good Afternoon $AXXA I know it might seem a bit quiet in #AXXALAND but please don't mistake it for no activity. We are really #KickingAXX on the back end here and you will see some great progress in no time, things are lining up. We will #ROCKTHEAXXABOAT SOON $AXXA
— Exxegroup (@exxegroup) April 22, 2022
$AXXA +6.32% nice green close..
$AXXA is going vertical soon imo.. $$$$$$
$AXXA looks like a bottom forming last run saw .04 watch for repeat..
$AXXA Chart - RSI at 30 on the daily, Big time OVERSOLD. Great chart setup for a solid bottom bounce!
Exciting updates and events are coming our way as per company twitter update.
$AXXA going over lots of exciting updates that could interest our #shareholders. One of them that really stands out is that might be able to report the YEAR-END ahead of the scheduled deadline $AXXA
— Exxegroup (@exxegroup) April 20, 2022
$AXXA RSI at 30 on the daily, Big time OVERSOLD. Great chart setup for a solid bottom bounce!
Exciting updates and events are coming our way as per company twitter update.
$AXXA going over lots of exciting updates that could interest our #shareholders. One of them that really stands out is that might be able to report the YEAR-END ahead of the scheduled deadline $AXXA
— Exxegroup (@exxegroup) April 20, 2022
$AXXA Chart - RSI at 30 on the daily, Big time OVERSOLD. Great chart setup for a solid bottom bounce!
Exciting updates and events are coming our way as per company twitter update.
$AXXA going over lots of exciting updates that could interest our #shareholders. One of them that really stands out is that might be able to report the YEAR-END ahead of the scheduled deadline $AXXA
— Exxegroup (@exxegroup) April 20, 2022
Good Morning Whales!
$AXXA nice twitter update - $AXXA going over lots of exciting updates that could interest our #shareholders. One of them that really stands out is that might be able to report the YEAR-END ahead of the scheduled deadline $AXXA
$AXXA going over lots of exciting updates that could interest our #shareholders. One of them that really stands out is that might be able to report the YEAR-END ahead of the scheduled deadline $AXXA
— Exxegroup (@exxegroup) April 20, 2022
$OTLC on watch due to Daily Chart increasing Volume and now crossing the 50 SMA. Accum/Dist on the rise as well..
Recently provided Year 2021 Financial Results:
https://www.globenewswire.com/news-release/2022/04/18/2423605/0/en/ONCOTELIC-PROVIDES-YE-2021-FINANCIAL-RESULTS-COMPARED-TO-YE-2020-PRODUCT-DEVELOPMET-INITIATIVES-AND-CORPORATE-UPDATE.html
$OTLC on watch due to Daily Chart increasing Volume and now crossing the 50 SMA. Accum/Dist on the rise as well.
Recently provided Year 2021 Financial Results:
https://www.globenewswire.com/news-release/2022/04/18/2423605/0/en/ONCOTELIC-PROVIDES-YE-2021-FINANCIAL-RESULTS-COMPARED-TO-YE-2020-PRODUCT-DEVELOPMET-INITIATIVES-AND-CORPORATE-UPDATE.html
$OTLC on watch due to Daily Chart increasing Volume and now crossing the 50 SMA. Accum/Dist on the rise as well.
Recently provided Year 2021 Financial Results:
https://www.globenewswire.com/news-release/2022/04/18/2423605/0/en/ONCOTELIC-PROVIDES-YE-2021-FINANCIAL-RESULTS-COMPARED-TO-YE-2020-PRODUCT-DEVELOPMET-INITIATIVES-AND-CORPORATE-UPDATE.html
Good Morning Whales!
$AXXA Chart - Nice consolidation and base forming at .019 - .02 range, giving us a chance at some cheaper shares before any other developments. Expecting many CATALYTS here $$
Nice Tweet out yesterday.
$AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
— Exxegroup (@exxegroup) April 19, 2022
$AXXA Chart - Nice consolidation and base forming at .019 - .02 range, giving us a chance at some cheaper shares before any other developments. Expecting many CATALYTS here $$$
Nice Tweet out yesterday.
$AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
— Exxegroup (@exxegroup) April 19, 2022
$AXXA Chart - Nice consolidation and base forming at .019 - .02 range, giving us a chance at some cheaper shares before any other developments. Expecting many CATALYTS here $$$
Nice Tweet out yesterday.
$AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
— Exxegroup (@exxegroup) April 19, 2022
$AXXA 's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
$AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
— Exxegroup (@exxegroup) April 19, 2022
$AXXA Twitter Update - $AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
$AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
— Exxegroup (@exxegroup) April 19, 2022
$AXXA Twitter Update - $AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
$AXXA's successfully completed 4 days of meetings with the #MyleOne #Swiss #German team. We reviewed key topics and lined-up plans for future #Growth. Lots of great developments. $AXXA's very pleased with the results and preparing a report $AXXA
— Exxegroup (@exxegroup) April 19, 2022
$OTLC ONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED TO YE 2020, PRODUCT DEVELOPMET INITIATIVES AND CORPORATE UPDATE
AGOURA HILLS, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Company”) (OTCQB:OTLC) today announced financial results for the full year ended December 31, 2021 (“FY 2021”) as compared to the full year ended December 31, 2020 (“FY 2020”), an update on its product and therapeutic development initiatives and other corporate updates. The financial results were based on the 2021 Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022.
Operating Activities
Net cash used in operating activities was approximately $4.3 million for FY 2021. This was due to the net loss of approximately $10.5 million, which was partially offset by a $1.5 million of R&D cost paid through debt from GMP, non-cash amortization of debt discounts and deferred financing costs of $1.4 million, non-cash stock-based compensation of $0.8 million, amortization and depreciation of intangibles and development equipment of $0.1 million, non-cash gain on conversion of debt and change in fair value of derivatives of $0.3 million, forgiveness of the PPP Loan of $0.3 million and changes in operating assets and liabilities of approximately $0.2 million.
https://www.otcmarkets.com/stock/OTLC/news/ONCOTELIC-PROVIDES-YE-2021-FINANCIAL-RESULTS-COMPARED-TO-YE-2020-PRODUCT-DEVELOPMET-INITIATIVES-AND-CORPORATE-UPDATE?id=352529
$OTLC ONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED TO YE 2020, PRODUCT DEVELOPMET INITIATIVES AND CORPORATE UPDATE
AGOURA HILLS, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Company”) (OTCQB:OTLC) today announced financial results for the full year ended December 31, 2021 (“FY 2021”) as compared to the full year ended December 31, 2020 (“FY 2020”), an update on its product and therapeutic development initiatives and other corporate updates. The financial results were based on the 2021 Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022.
https://www.otcmarkets.com/stock/OTLC/news/ONCOTELIC-PROVIDES-YE-2021-FINANCIAL-RESULTS-COMPARED-TO-YE-2020-PRODUCT-DEVELOPMET-INITIATIVES-AND-CORPORATE-UPDATE?id=352529
$OTLC ONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED TO YE 2020, PRODUCT DEVELOPMET INITIATIVES AND CORPORATE UPDATE
AGOURA HILLS, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Company”) (OTCQB:OTLC) today announced financial results for the full year ended December 31, 2021 (“FY 2021”) as compared to the full year ended December 31, 2020 (“FY 2020”), an update on its product and therapeutic development initiatives and other corporate updates. The financial results were based on the 2021 Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2022.
https://www.otcmarkets.com/stock/OTLC/news/ONCOTELIC-PROVIDES-YE-2021-FINANCIAL-RESULTS-COMPARED-TO-YE-2020-PRODUCT-DEVELOPMET-INITIATIVES-AND-CORPORATE-UPDATE?id=352529
Good Morning Whales!
This Little Known Cancer Play has been Crushing the Market (ADGI, OTLC, DVAX, PACB, SAVA, NVAX, IMGN, BNTX)
https://www.wallstreetpr.com/this-little-known-cancer-play-has-been-crushing-the-market-adgi-otlc-dvax-pacb-sava-nvax-imgn-bntx-46481
This Little Known Cancer Play has been Crushing the Market (ADGI, OTLC, DVAX, PACB, SAVA, NVAX, IMGN, BNTX)
https://www.wallstreetpr.com/this-little-known-cancer-play-has-been-crushing-the-market-adgi-otlc-dvax-pacb-sava-nvax-imgn-bntx-46481
This Little Known Cancer Play has been Crushing the Market (ADGI, OTLC, DVAX, PACB, SAVA, NVAX, IMGN, BNTX)
https://www.wallstreetpr.com/this-little-known-cancer-play-has-been-crushing-the-market-adgi-otlc-dvax-pacb-sava-nvax-imgn-bntx-46481
This Little Known Cancer Play has been Crushing the Market (ADGI, OTLC, DVAX, PACB, SAVA, NVAX, IMGN, BNTX)
https://www.wallstreetpr.com/this-little-known-cancer-play-has-been-crushing-the-market-adgi-otlc-dvax-pacb-sava-nvax-imgn-bntx-46481
$OTLC Company Profile and Technical Chart Analysis.
$OTLC Company Profile and Technical Chart Analysis
$OTLC Company Profile and Technical Chart Analysis
Good Morning Whales!